June 18, 2021 10:57 AM EDTUpdated 11:11 AM

Jim Greenwood opens new policy shop, with an eye on drug price controls; Moderna, CRISPR, Mustang receive tax breaks in Massachusetts

Josh Sullivan

Zachary Brennan

Senior Editor

Capitol Hill heavyweight Jim Greenwood is taking his decades of experience in the intertwining worlds of biopharma and Congress to the law firm DLA Piper …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Jim Greenwood opens new policy shop, with an eye on drug price controls; Moderna, CRISPR, Mustang receive tax breaks in Massachusetts

Josh Sullivan

Zachary Brennan

Senior Editor

Sign up to read this article for free.

CagriSema’s weight loss data disappointed. What does Novo do next?

The Endpoints 2024 winners and losers list: Who was up and who was down in biopharma

FDA approves Lilly's Zepbound for sleep apnea, likely cracking open Medicare market

CMS explains what went into its first round of drug price negotiations

Three drugmakers sue US over 340B discounts to STD clinics they allege don’t qualify

Vertex gets 'vanza triple' approval and Trikafta expansion — with boxed warnings

Jim Green­wood opens new pol­i­cy shop, with an eye on drug price con­trols; Mod­er­na, CRISPR, Mus­tang re­ceive tax breaks in Mass­a­chu­setts

Senior Editor

Sign up to read this article for free.

more like this

Jim Greenwood opens new policy shop, with an eye on drug price controls; Moderna, CRISPR, Mustang receive tax breaks in Massachusetts